RG
TDOC icon

Rathbones Group’s Teladoc Health TDOC Stock Holding History

Rathbones Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,660
Closed -$372K – 640
2024
Q1 		$372K Sell
24,660
-1,327
-5% -$24.1K ﹤0.01% 455
2023
Q4 		$560K Sell
25,987
-3,381
-12% -$62.4K ﹤0.01% 384
2023
Q3 		$546K Buy
+29,368
New +$686K ﹤0.01% 388
2021
Q4 		– Sell
-2,875
Closed -$365K – 437
2021
Q3 		$365K Sell
2,875
-764
-21% -$111K ﹤0.01% 335
2021
Q2 		$605K Buy
3,639
+5
+0.1% +$810 0.01% 291
2021
Q1 		$660K Buy
3,634
+755
+26% +$175K 0.01% 268
2020
Q4 		$576K Buy
+2,879
New +$585K 0.01% 268

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Rathbones Group's TDOC Position: Q2 2024 in Review

Rathbones Group sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 24,660 shares — an estimated $372K sold.

Rathbones Group first reported a position in TDOC in Q4 2020 and held it in 7 quarters. The position peaked at $660K in Q1 2021. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Rathbones Group reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Rathbones Group sold 24,660 Teladoc Health shares in Q2 2024, an estimated $372K.
  • Rathbones Group first reported a position in Teladoc Health in Q4 2020 and held it in 7 quarters.
  • Rathbones Group's Teladoc Health position peaked at $660K in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Rathbones Group's 13F filing for Q2 2024, filed 9 Aug 2024.